Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GDF11 Alleviates Pathological Myocardial Remodeling in Diabetic Cardiomyopathy Through SIRT1-Dependent Regulation of Oxidative Stress and Apoptosis
Hanzhao Zhu, Liyun Zhang, Mengen Zhai, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23

Showing 23 citing articles:

Regulation of Myostatin on the Growth and Development of Skeletal Muscle
Mingming Chen, Yiping Zhao, Yue Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 90
Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation
Jing Zhang, Guolong Wang, Yuxuan Shi, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Hydrogen sulfide antagonizes formaldehyde-induced ferroptosis via preventing ferritinophagy by upregulation of GDF11 in HT22 cells
Yu-Hui Tang, Lei Wu, Honglin Huang, et al.
Toxicology (2023) Vol. 491, pp. 153517-153517
Closed Access | Times Cited: 13
GDF11 overexpression alleviates sepsis-induced lung microvascular endothelial barrier damage by activating SIRT1/NOX4 signaling to inhibit ferroptosis
Zhixiang Wu, Qiong Xi, Qin Zhao, et al.
Shock (2024) Vol. 62, Iss. 2, pp. 245-254
Open Access | Times Cited: 5
Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
Jaqueline da Silva, Renata Guedes de Jesus Gonçalves, Juliana Ferreira Vasques, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 240-240
Open Access | Times Cited: 22
GDF15 attenuates sepsis-induced myocardial dysfunction by inhibiting cardiomyocytes ferroptosis via the SOCS1/GPX4 signaling pathway
Xiayun Li, He Sun, Liyun Zhang, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176894-176894
Closed Access | Times Cited: 4
Non-coding RNA as a key regulator and novel target of apoptosis in diabetic cardiomyopathy: Current status and future prospects
Yicheng Liu, Jie Yuan, Yuhang Zhang, et al.
Cellular Signalling (2025) Vol. 128, pp. 111632-111632
Closed Access
GDF11 mitigates high glucose-induced cardiomyocytes apoptosis by inhibiting the ALKBH5-FOXO3-CDR1as/Hippo signaling pathway
Yingchun Shao, Mengmeng Li, Yanying Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 3, pp. 119656-119656
Open Access | Times Cited: 3
Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease
Xing-Jian Zhang, Congcong Liu, Zuo‐Lin Li, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11/15, sirtuin 1, NAD+, NLRP3, DNA/RNA damage, and klotho
Pavel Borský, Drahomíra Holmannová, Ctirad Andrýs, et al.
Biogerontology (2023) Vol. 24, Iss. 6, pp. 937-955
Open Access | Times Cited: 7
Bergenin alleviates myocardial ischemia‐reperfusion injury via SIRT1 signaling
Yingying Liu, Yanzhen Tan, Guojie Cao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114100-114100
Open Access | Times Cited: 11
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Yung Ting Hsiao, Ippei Shimizu, Yohko Yoshida, et al.
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 10
Grpel2 maintains cardiomyocyte survival in diabetic cardiomyopathy through DLST-mediated mitochondrial dysfunction: a proof-of-concept study
Rongjin Yang, Xiaomeng Zhang, Yunyun Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Protein PDK4 Interacts with HMGCS2 to Facilitate High Glucoseinduced Myocardial Injuries
Wenliang Tan, Huogeng Bao, Ziming Liu, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 10, pp. 1104-1115
Closed Access | Times Cited: 7
Growth differentiation factor 11: A new hope for the treatment of cardiovascular diseases
Yingchun Shao, Yanhong Wang, Jiazhen Xu, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 82-93
Closed Access | Times Cited: 3
The regulatory effect of growth differentiation factor 11 on different cells
Yingchun Shao, Ting Liu, Xiaobo Wen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
GDF11 and aging biology - controversies resolved and pending
Laura Ben Driss, John Lian, Ryan G. Walker, et al.
The Journal of Cardiovascular Aging (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 2
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy
Lu Zhou, Wating Su, Yafeng Wang, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 2, pp. 732-744
Closed Access | Times Cited: 2
Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease
Xing-Jian Zhang, Congcong Liu, Zuo‐Lin Li, et al.
Research Square (Research Square) (2024)
Open Access
GDF11 evokes lung injury, inflammation, and fibrosis in mice through the ALK5-Smad2/3 signaling pathway
Qian Li, Hanchao Li, Li Zhu, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 11, pp. 2036-2058
Closed Access
Novel insights into the pleiotropic health effects of growth differentiation factor 11 gained from genome-wide association studies in population biobanks
Jessica Strosahl, Kaixiong Ye, Robert Pazdro
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access
Loss of MD1 Promotes Inflammatory and Apoptotic Atrial Remodelling in Diabetic Cardiomyopathy by Activating the TLR4/NF-κB Signalling Pathway
Tonghuan Shi, Guangji Wang, Jianye Peng, et al.
Pharmacology (2023) Vol. 108, Iss. 4, pp. 311-320
Closed Access | Times Cited: 1
Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping
Dingjun Hao, Yue Qin, Shijie Zhou, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 3, pp. 335-347
Open Access | Times Cited: 1
Page 1

Scroll to top